{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:54:47Z","timestamp":1790949287442,"version":"4.1.0"},"reference-count":75,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brain Drug Discovery Center, Department of Pharmaceutical Sciences, SOP, TTUSHC"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Stroke leads to significant disability in most patients, whereas cancer elevates the occurrence of stroke. The incidence of cancer-associated stroke (CAS) is projected to rise as a result of improvements in cancer therapies. Various forms of cancer have been demonstrated to be linked to ischemic stroke. Cancer might influence stroke pathophysiology either directly or through coagulation that creates a hypercoagulative state, in addition to infections. Treatment methods for cancer, including chemotherapy, radiotherapy, and surgery, have all been demonstrated to increase the risk of stroke as well. This review discusses the subtypes, epidemiology, pathophysiology, mechanisms of stroke within cancer patients, biomarkers, and signaling pathways of stroke in cancer while providing vital information on the involved transcription factors, treatment, and management of patients with cancer-associated ischemic stroke. Atherosclerosis, extracellular vesicles (EVs), and signaling biomolecules can also affect CAS. Overall, stroke is a significant and not uncommon complication of cancer, and there is an immediate demand for neurologists and oncologists to create strategies for screening and preventing strokes in cancer patients.<\/jats:p>","DOI":"10.3390\/biology14010050","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T03:48:11Z","timestamp":1736480891000},"page":"50","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Insights into Cancer-Associated Thrombosis Leading Towards Ischemic Stroke"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-3629","authenticated-orcid":false,"given":"Surajit","family":"Hansda","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-0096","authenticated-orcid":false,"given":"Hiranmoy","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0030-4220(94)90332-8","article-title":"Prevalence of detectable carotid artery calcifications on panoramic radiographs of recent stroke victims","volume":"77","author":"Friedlander","year":"1994","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2019.0591","article-title":"Tailoring the approach to embolic stroke of undetermined source: A review","volume":"76","author":"Kamel","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e012858","DOI":"10.1161\/JAHA.119.012858","article-title":"Prevalence and overlap of potential embolic sources in patients with embolic stroke of undetermined source","volume":"8","author":"Ntaios","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.11.016","article-title":"Trends in cancer diagnoses among inpatients hospitalized with stroke","volume":"22","author":"Sanossian","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_6","first-page":"781","article-title":"Arterial thromboembolic events preceding the diagnosis of cancer in older persons","volume":"133","author":"Navi","year":"2019","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/eurheartj\/ehab171","article-title":"Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis","volume":"42","author":"Grilz","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1634\/theoncologist.2016-0214","article-title":"Cancer and venous thromboembolic disease: A review","volume":"22","author":"Donnellan","year":"2017","journal-title":"Oncologist"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.neo.7900263","article-title":"The hypercoagulable state of malignancy: Pathogenesis and current debate","volume":"4","author":"Caine","year":"2002","journal-title":"Neoplasia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: Signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jjcc.2018.02.011","article-title":"Mechanism and management of cancer-associated thrombosis","volume":"72","author":"Mukai","year":"2018","journal-title":"J. Cardiol."},{"key":"ref_14","unstructured":"Zaanona, M.I.A., and Mantha, S. (2023). Cancer-Associated Thrombosis, StatPearls Publishing."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e012877","DOI":"10.1161\/JAHA.119.012877","article-title":"Inherited thrombophilia and the risk of arterial ischemic stroke: A systematic review and meta-analysis","volume":"8","author":"Chiasakul","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1164\/ajrccm.158.5.9712022","article-title":"Hereditary thrombophilia and venous thromboembolism","volume":"158","author":"Murin","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1076029620954282","DOI":"10.1177\/1076029620954282","article-title":"Cancer-associated thrombosis: Risk factors, molecular mechanisms, future management","volume":"26","author":"Hamza","year":"2020","journal-title":"Clin. Appl. Thromb.\/Hemost."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100742","DOI":"10.1016\/j.esmoop.2022.100742","article-title":"Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations","volume":"7","author":"Wang","year":"2022","journal-title":"ESMO Open"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12959-024-00607-6","article-title":"Venous thromboembolism in patients with acute myeloid leukemia: Development of a predictive model","volume":"22","author":"Mitrovic","year":"2024","journal-title":"Thromb. J."},{"key":"ref_20","first-page":"173","article-title":"Venous and arterial thromboembolism in patients with cancer: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Gervaso","year":"2021","journal-title":"Cardio Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/STROKEAHA.120.032002","article-title":"Cancer and embolic stroke of undetermined source","volume":"52","author":"Navi","year":"2021","journal-title":"Stroke"},{"key":"ref_22","first-page":"100148","article-title":"Non-bacterial thrombotic endocarditis during treatment for EGFR mutation positive lung cancer","volume":"5","author":"Moore","year":"2022","journal-title":"Curr. Probl. Cancer Case Rep."},{"key":"ref_23","unstructured":"Centers for Disease Control and Prevention (2009). Prevalence and most common causes of disability among adults\u2014United States, 2005. MMWRMorb. Mortal. Wkly. Rep., 58, 421."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25227","article-title":"Ischemic stroke in cancer patients: A review of an underappreciated pathology","volume":"83","author":"Navi","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e235002","DOI":"10.1001\/jamanetworkopen.2023.5002","article-title":"Association of stroke at young age with new cancer in the years after stroke among patients in the Netherlands","volume":"6","author":"Verhoeven","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lee, P.N., Forey, B.A., and Coombs, K.J. (2012). Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-385"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108989","DOI":"10.18632\/oncotarget.22480","article-title":"Increased risk of brain cancer incidence in stroke patients: A clinical case series, population-based and longitudinal follow-up study","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ene.14037","article-title":"Cancer prevalence higher in stroke patients than in the general population: The Dutch String-of-Pearls Institute (PSI) Stroke study","volume":"27","author":"Wilbers","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_29","first-page":"693","article-title":"Deep vein thrombosis in primary care: Possible malignancy?","volume":"56","author":"Oudega","year":"2006","journal-title":"Br. J. Gen. Pract."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199804233381701","article-title":"The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism","volume":"338","author":"Steffensen","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.mayocp.2022.09.003","article-title":"Ischemic stroke in patients with malignancy","volume":"97","author":"Sener","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1038\/s41467-019-13120-6","article-title":"Stroke among cancer patients","volume":"10","author":"Zaorsky","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lun, R., Roy, D.C., Hao, Y., Deka, R., Huang, W.-K., Navi, B.B., Siegal, D.M., Ramsay, T., Fergusson, D., and Shorr, R. (2022). Incidence of stroke in the first year after diagnosis of cancer\u2014A systematic review and meta-analysis. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.966190"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2354947","DOI":"10.1001\/jamanetworkopen.2023.54947","article-title":"Stroke Risk in Survivors of Head and Neck Cancer","volume":"7","author":"Yip","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.thromres.2024.03.019","article-title":"Cancer patients and ischemic stroke","volume":"237","author":"Kawano","year":"2024","journal-title":"Thromb. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11060-009-9818-3","article-title":"Stroke in cancer patients: A risk factor analysis","volume":"94","author":"Stefan","year":"2009","journal-title":"J. Neuro-Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5853\/jos.2019.02278","article-title":"Cancer-related stroke: An emerging subtype of ischemic stroke with unique pathomechanisms","volume":"22","author":"Bang","year":"2020","journal-title":"J. Stroke"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s11764-021-01122-7","article-title":"Is stroke incidence increased in survivors of adult cancers? A systematic review and meta-analysis","volume":"16","author":"Turner","year":"2022","journal-title":"J. Cancer Surviv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.24325","article-title":"Association between incident cancer and subsequent stroke","volume":"77","author":"Navi","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bang, O.Y., Chung, J.-W., Lee, M.J., Kim, S.J., Cho, Y.H., Kim, G.-M., Chung, C.-S., Lee, K.H., Ahn, M.-J., and Moon, G.J. (2016). Cancer cell-derived extracellular vesicles are associated with coagulopathy causing ischemic stroke via tissue factor-independent way: The OASIS-CANCER study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159170"},{"key":"ref_41","first-page":"2133","article-title":"Tissue factor\u2013positive neutrophils bind to injured endothelial wall and initiate thrombus formation","volume":"120","author":"Darbousset","year":"2012","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1160\/TH12-05-0280","article-title":"Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis","volume":"108","author":"Campello","year":"2012","journal-title":"Thromb. Haemost."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Beck, S., Hochreiter, B., and Schmid, J.A. (2022). Extracellular vesicles linking inflammation, cancer and thrombotic risks. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.859863"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Leal, A.C., Mizurini, D.M., Gomes, T., Rochael, N.C., Saraiva, E.M., Dias, M.S., Werneck, C.C., Sielski, M.S., Vicente, C.P., and Monteiro, R.Q. (2017). Tumor-derived exosomes induce the formation of neutrophil extracellular traps: Implications for the establishment of cancer-associated thrombosis. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-06893-7"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Rajam\u00e4ki, K., Lappalainen, J., O\u00f6rni, K., V\u00e4lim\u00e4ki, E., Matikainen, S., Kovanen, P.T., and Eklund, K.K. (2010). Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: A novel link between cholesterol metabolism and inflammation. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011765"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehq146","article-title":"A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women","volume":"31","author":"Conen","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: Causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1161\/STROKEAHA.121.034388","article-title":"Inflammation and Stroke Risk: A New Target for Prevention","volume":"52","author":"Kelly","year":"2021","journal-title":"Stroke"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/17474930241227385","article-title":"Diagnosing cancer-associated ischemic stroke: A systematic review of hematological biomarkers","volume":"19","author":"Wenstrup","year":"2024","journal-title":"Int. J. Stroke"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.2147\/JIR.S493406","article-title":"Pathogenesis and Biomarkers of Cancer-Related Ischemic Stroke","volume":"17","author":"Cen","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis","volume":"104","author":"Mulder","year":"2019","journal-title":"haematologica"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jocn.2018.08.018","article-title":"Ability of the Khorana score to predict recurrent thromboembolism in cancer patients with ischemic stroke","volume":"57","author":"Murthy","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jtha.2023.03.037","article-title":"Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort","volume":"21","author":"Verzeroli","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.semcancer.2023.04.006","article-title":"Insight into the transcription factors regulating Ischemic stroke and glioma in response to shared stimuli","volume":"92","author":"Waseem","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Zhu, H., Hu, S., Li, Y., Sun, Y., Xiong, X., Hu, X., Chen, J., and Qiu, S. (2022). Interleukins and Ischemic Stroke. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.828447"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"H796","DOI":"10.1152\/ajpheart.00712.2012","article-title":"Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function","volume":"304","author":"Shi","year":"2013","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1073\/pnas.0508235103","article-title":"Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes","volume":"103","author":"Das","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1084\/jem.20031132","article-title":"KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation","volume":"199","author":"SenBanerjee","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.104.525774","article-title":"Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells","volume":"112","author":"Mir","year":"2005","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e91700","DOI":"10.1172\/jci.insight.91700","article-title":"KLF2 and KLF4 control endothelial identity and vascular integrity","volume":"2","author":"Sangwung","year":"2017","journal-title":"JCI Insight"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1161\/01.RES.0000267856.00713.0a","article-title":"Role of Kr\u00fcppel-like transcription factors in endothelial biology","volume":"100","author":"Atkins","year":"2007","journal-title":"Circ. Res."},{"key":"ref_63","first-page":"779","article-title":"Cancer-associated stroke: Pathophysiology, detection and management (Review)","volume":"54","author":"Dardiotis","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Huang, B., Lang, X., and Li, X. (2022). The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1023177"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","article-title":"TNF-alpha\/NF-kappaB\/Snail pathway in cancer cell migration and invasion","volume":"102","author":"Wu","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jacbts.2023.03.017","article-title":"Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism","volume":"8","author":"Potere","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Rascio, F., Spadaccino, F., Rocchetti, M.T., Castellano, G., Stallone, G., Netti, G.S., and Ranieri, E. (2021). The Pathogenic Role of PI3K\/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review. Cancers, 13.","DOI":"10.3390\/cancers13163949"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOH.0000000000000521","article-title":"Cancer cell-derived tissue factor-positive extracellular vesicles: Biomarkers of thrombosis and survival","volume":"26","author":"Hisada","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/ijc.28217","article-title":"Human V2V2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors","volume":"133","author":"Aggarwal","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/STROKEAHA.118.021948","article-title":"Cancer Exacerbates Ischemic Brain Injury via Nrp1 (Neuropilin 1)-Mediated Accumulation of Regulatory T Cells Within the Tumor","volume":"49","author":"Wang","year":"2018","journal-title":"Stroke"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"102475","DOI":"10.1016\/j.rpth.2024.102475","article-title":"Modeling cancer-associated hypercoagulability using glioblastoma spheroids in microfluidic chips","volume":"8","author":"Kapteijn","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"109200","DOI":"10.1016\/j.thromres.2024.109200","article-title":"The effects of an aggressive breast tumor on thrombosis after antithrombin downregulation in a hypercoagulable mouse model","volume":"244","author":"Heestermans","year":"2024","journal-title":"Thromb. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/STROKEAHA.118.021373","article-title":"Risk of ischemic and hemorrhagic strokes in occult and manifest cancers","volume":"49","author":"Andersen","year":"2018","journal-title":"Stroke"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.10.012","article-title":"Subcutaneous heparin therapy for patients with cancer-associated stroke","volume":"28","author":"Kawano","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5853\/jos.2023.03279","article-title":"Cancer-Associated Stroke: Thrombosis Mechanism, Diagnosis, Outcome, and Therapeutic Strategies","volume":"26","author":"Heo","year":"2024","journal-title":"J. Stroke"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/14\/1\/50\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:26:08Z","timestamp":1759919168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/14\/1\/50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["biology14010050"],"URL":"https:\/\/doi.org\/10.3390\/biology14010050","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]}}}